Acumen Pharmaceuticals
ABOS
ABOS
81 hedge funds and large institutions have $105M invested in Acumen Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+1
Holders Change %
+1.25%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
23
Increased
22
Reduced
19
Closed
22
Calls
$737K
Puts
$2.11M
Net Calls
-$1.37M
Net Calls Change
+$1.22M
Top Buyers
| 1 |
1
BlackRock
New York
|
$5.22M |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$1.97M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$1.06M |
| 4 |
4
Renaissance Technologies
New York
|
$818K |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$4.59M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CAS
101
CTC Alternative Strategies
Chicago,
Illinois
| – | -$45K | -11,100 | Closed |
|
|
IWC
102
Integrated Wealth Concepts
Waltham,
Massachusetts
| – | -$40.9K | -10,100 | Closed |
|
103
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$5 | -1,247 | Closed |
|